Cargando…
T-cell immunotherapy with a chimeric receptor against CD38 is effective in eradicating chemotherapy-resistant B-cell lymphoma cells overexpressing survivin induced by BMI-1
| Autores principales: | , , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Nature Publishing Group
2012
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3389163/ https://www.ncbi.nlm.nih.gov/pubmed/22829977 http://dx.doi.org/10.1038/bcj.2012.21 |
| _version_ | 1782237285334384640 |
|---|---|
| author | Bhattacharyya, J Mihara, K Kitanaka, A Yanagihara, K Kubo, T Takei, Y Kimura, A Takihara, Y |
| author_facet | Bhattacharyya, J Mihara, K Kitanaka, A Yanagihara, K Kubo, T Takei, Y Kimura, A Takihara, Y |
| author_sort | Bhattacharyya, J |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-3389163 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2012 |
| publisher | Nature Publishing Group |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-33891632012-07-05 T-cell immunotherapy with a chimeric receptor against CD38 is effective in eradicating chemotherapy-resistant B-cell lymphoma cells overexpressing survivin induced by BMI-1 Bhattacharyya, J Mihara, K Kitanaka, A Yanagihara, K Kubo, T Takei, Y Kimura, A Takihara, Y Blood Cancer J Letter to the Editor Nature Publishing Group 2012-06 2012-06-22 /pmc/articles/PMC3389163/ /pubmed/22829977 http://dx.doi.org/10.1038/bcj.2012.21 Text en Copyright © 2012 Macmillan Publishers Limited http://creativecommons.org/licenses/by-nc-nd/3.0/ This work is licensed under the Creative Commons Attribution-NonCommercial-No Derivative Works 3.0 Unported License. To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/3.0/ |
| spellingShingle | Letter to the Editor Bhattacharyya, J Mihara, K Kitanaka, A Yanagihara, K Kubo, T Takei, Y Kimura, A Takihara, Y T-cell immunotherapy with a chimeric receptor against CD38 is effective in eradicating chemotherapy-resistant B-cell lymphoma cells overexpressing survivin induced by BMI-1 |
| title | T-cell immunotherapy with a chimeric receptor against CD38 is effective in eradicating chemotherapy-resistant B-cell lymphoma cells overexpressing survivin induced by BMI-1 |
| title_full | T-cell immunotherapy with a chimeric receptor against CD38 is effective in eradicating chemotherapy-resistant B-cell lymphoma cells overexpressing survivin induced by BMI-1 |
| title_fullStr | T-cell immunotherapy with a chimeric receptor against CD38 is effective in eradicating chemotherapy-resistant B-cell lymphoma cells overexpressing survivin induced by BMI-1 |
| title_full_unstemmed | T-cell immunotherapy with a chimeric receptor against CD38 is effective in eradicating chemotherapy-resistant B-cell lymphoma cells overexpressing survivin induced by BMI-1 |
| title_short | T-cell immunotherapy with a chimeric receptor against CD38 is effective in eradicating chemotherapy-resistant B-cell lymphoma cells overexpressing survivin induced by BMI-1 |
| title_sort | t-cell immunotherapy with a chimeric receptor against cd38 is effective in eradicating chemotherapy-resistant b-cell lymphoma cells overexpressing survivin induced by bmi-1 |
| topic | Letter to the Editor |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3389163/ https://www.ncbi.nlm.nih.gov/pubmed/22829977 http://dx.doi.org/10.1038/bcj.2012.21 |
| work_keys_str_mv | AT bhattacharyyaj tcellimmunotherapywithachimericreceptoragainstcd38iseffectiveineradicatingchemotherapyresistantbcelllymphomacellsoverexpressingsurvivininducedbybmi1 AT miharak tcellimmunotherapywithachimericreceptoragainstcd38iseffectiveineradicatingchemotherapyresistantbcelllymphomacellsoverexpressingsurvivininducedbybmi1 AT kitanakaa tcellimmunotherapywithachimericreceptoragainstcd38iseffectiveineradicatingchemotherapyresistantbcelllymphomacellsoverexpressingsurvivininducedbybmi1 AT yanagiharak tcellimmunotherapywithachimericreceptoragainstcd38iseffectiveineradicatingchemotherapyresistantbcelllymphomacellsoverexpressingsurvivininducedbybmi1 AT kubot tcellimmunotherapywithachimericreceptoragainstcd38iseffectiveineradicatingchemotherapyresistantbcelllymphomacellsoverexpressingsurvivininducedbybmi1 AT takeiy tcellimmunotherapywithachimericreceptoragainstcd38iseffectiveineradicatingchemotherapyresistantbcelllymphomacellsoverexpressingsurvivininducedbybmi1 AT kimuraa tcellimmunotherapywithachimericreceptoragainstcd38iseffectiveineradicatingchemotherapyresistantbcelllymphomacellsoverexpressingsurvivininducedbybmi1 AT takiharay tcellimmunotherapywithachimericreceptoragainstcd38iseffectiveineradicatingchemotherapyresistantbcelllymphomacellsoverexpressingsurvivininducedbybmi1 |